EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study

Alexander T Hong, Ivan Y Luu, Forest Lin, Laura Shin, Chiu-Hsieh Hsu, Chia-Ding Shih, David G Armstrong, Tze-Woei Tan iD

Diabetes Care · 01.10.2025 · 48 (10) · 1728-1736

DOI: 10.2337/dc25-0292 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes Care, online erschienen am 25.06.2025. Verfasst von Alexander T Hong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, University of Southern California, Los Angeles, CA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Amputation, Surgical, Sodium-Glucose Transporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To compare the risk of lower-extremity amputations (LEAs) between new users of glucagon-like peptide 1 receptor agonists (GLP-1RAs) versus sodium–glucose cotransporter 2 inhibitors (SGLT2is). RESEARCH DESIGN AND METHODS This retrospective cohort study used TriNetX, a federated electronic health records network, including adults with type 2 diabetes who initiated GLP-1RAs or SGLT2is between May 2013 and March 2025. Propensity score matching (1:1) was used to balance demographics, comorbidities, medications, and laboratory values. Major (above-ankle) amputation–free survival was evaluated using Kaplan-Meier curves, while risks of major and minor LEAs, diabetic foot ulcers (DFUs), and mortality were estimated using hazard ratios (HRs) with 95% CIs. RESULTS The matched cohorts included 180,740 GLP-1RA and 180,740 SGLT2i recipients. At 3 years, the GLP-1RA cohort was associated with greater major amputation–free survival (99.69% vs. 99.64%, P = 0.001) compared with the SGLT2i cohort. Additionally, GLP-1RA treatment was associated with a lower risk of major LEAs (HR 0.77 [95% CI 0.66, 0.90]), minor LEAs (HR 0.73 [95% CI 0.63, 0.84]), DFUs (HR 0.92 [95% CI 0.87, 0.96]), and mortality (HR 0.66 [95% CI 0.63, 0.69]). Risk reduction for major LEAs remained significant in individuals with peripheral artery disease (HR 0.68 [95% CI 0.56, 0.82]) and DFUs (HR 0.70 [95% CI 0.58, 0.84]). CONCLUSIONS GLP-1RA treatment was associated with greater major amputation–free survival compared with SGLT2i in people with type 2 diabetes, particularly in high-risk subgroups. Prospective studies are needed to confirm findings and inform selection of glucose-lowering therapies for people at risk for diabetes-related amputations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Amputation, SurgicalSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor AgonistsLower ExtremityHypoglycemic AgentsHumansMaleRetrospective StudiesFemaleMiddle AgedAgedDiabetic Foot

Substanzen

Sodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Autor:innen und Institutionen

  • Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Mel & Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ.

ORCID-Profile: Tze-Woei Tan

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Hong, A. T., Luu, I. Y., Lin, F., Shin, L., Hsu, C. H., Shih, C. D., Armstrong, D. G., & Tan, T. W. (2025). Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. Diabetes Care, 48(10), 1728-1736. https://doi.org/10.2337/dc25-0292

Vancouver

Hong AT, Luu IY, Lin F, Shin L, Hsu CH, Shih CD, et al. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. Diabetes Care. 2025;48(10):1728-1736. doi:10.2337/dc25-0292

BibTeX
@article{Hong2025,
  author = {Hong, Alexander T and Luu, Ivan Y and Lin, Forest and Shin, Laura and Hsu, Chiu-Hsieh and Shih, Chia-Ding and Armstrong, David G and Tan, Tze-Woei},
  title = {Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study},
  journal = {Diabetes Care},
  year = {2025},
  volume = {48},
  number = {10},
  pages = {1728--1736},
  doi = {10.2337/dc25-0292}
}
Kostenlos starten →